New York, NY -- (SBWIRE) -- 02/01/2014 -- To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
StockMarketIntel.com issues a special report on the following stocks: Community Health Systems (NYSE:CYH), Amarin Corporation plc (ADR) (NASDAQ:AMRN), Navidea Biopharmaceuticals Inc (NYSEMKT:NAVB), Allergan, Inc. (NYSE:AGN)
Community Health Systems (NYSE:CYH) gained 2.73%, trading on 2.62 million shares, to end the trade at $41.41. If we look at its trading history of the past 52 weeks, the share price suffered a low of $36.52 and was moved to the maximum level of $51.29. The stock changed hands in a range of $40.04 to $42.23, bringing its market capitalization to about $4.69 billion. Community Health Systems, Inc. is an operator of hospitals in the United States. The Company provides healthcare services through the hospitals that it owns and operates in non-urban and selected urban markets throughout the United States.
What was the Moving Force behind CYH on Bullish Run? Read This Research Report
Amarin Corporation plc (ADR) (NASDAQ:AMRN) added 1.67%, to complete the trading session at $1.83, with a total volume of 2.63 million shares. The stock, on average, trades on a volume of 7.90 million shares. In the past 52 weeks, the share price has not declined below $1.36 and above $8.98. It floated in a range of $1.75 to $1.83 during the last trading session, with a beta value of 1.07. Its market capitalization now moved to about $315.94 million. Amarin Corporation plc (Amarin) is a late-stage biopharmaceutical -company with expertise in lipid science focused on the treatment of cardiovascular disease. The Company’s product candidate is AMR101, an ultra-pure omega-3 fatty acid.
For How Long AMRN will fight for Profitability? Read This Trend Analysis report
Navidea Biopharmaceuticals Inc (NYSEMKT:NAVB) recorded a gain of 1.73% and was in a range of $1.66-$1.80 before closing at $1.76. The share price hit its 52-week low of $1.11 and $3.59 was the best price. The stock completed the day with a total volume of 2.56 million shares, versus an average volume of 1.14 million shares. Navidea Biopharmaceuticals, Inc. (Navidea), formerly Neoprobe Corporation, is a biopharmaceutical company focused on the development and commercialization of precision diagnostic agents. As of December 31, 2011, the Company’s radiopharmaceutical development programs included Lymphoseek (Lymphoseek, Kit for the Preparation of Technetium Tc99m for Injection), a radiopharmaceutical agent for lymph node mapping; AZD4694, an imaging agent, and RIGScan, a tumor antigen-specific targeting agent.
For How Long NAVB Gloss will Attract Investors? Find out via this report
Allergan, Inc. (NYSE:AGN) declined -0.44% yesterday, bringing its market capitalization around $34.05 billion. The total number of shares that changed hands during the session was 2.54 million shares, as compared to average trading volume of 2.65 million shares. The share price, after opening at $113.68, made a high of $115.84 and hovered above $112.92 to end the day at $114.60. Allergan, Inc. is a multi-specialty health care Company focused on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products. The Company’s segments include specialty pharmaceuticals, which produces a range of pharmaceutical products, including ophthalmic products for dry eye, glaucoma, inflammation, infection, allergy and retinal disease.
Will AGN Bounce Back After yesterday’s Sharp Sell off? Find Out Here
To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)